Stem cell transplant with half-matched donor and cord blood
Part of Blood & lymphatic, Cancer, Immune system & allergy clinical trials.
This trial tests a new way to do a stem cell transplant for people with hard-to-treat blood cancers. It combines a half-matched family donor (haploidentical) with a cord blood unit to help the transplant work better.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older.
- You have a blood cancer such as AML, ALL, MDS, or high-risk lymphoma.
- If you have leukemia, it must be in remission (CR1, CR2, CR3, or CRi).
- You cannot have a matched related or unrelated donor, so this trial uses a half-matched family donor and a cord blood unit.
- Your organs (kidneys, liver, lungs, heart) must be working well enough, and you must be in good general health (ECOG less than 2).
- You cannot have had a prior stem cell transplant or CAR-T therapy in the last 6 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies transplanting healthy blood-forming cells from an umbilical cord blood donor who is not related to you. It may help people with certain blood cancers, immune disorders, or other serious diseases when a standard transplant plan is needed.
This Phase 1 trial tests a special bone marrow transplant using a related “half-matched” donor (haploidentical), without a specific immune-suppressing medicine (“IS-free”). It’s for adults with certain high-risk AML or MDS to see if this approach can improve control of the disease while tracking safety.
This study tests whether using cord blood stem cells (collected from umbilical cords after birth) can help treat high-risk blood cancers in children and young adults when a matched donor is not quickly available. Cord blood transplants may help prevent cancer from coming back.
This trial studies a type of stem cell transplant (bone marrow transplant) that uses a donor who is only half-matched to the patient, often a parent or sibling. It is for children and young adults with certain blood diseases, including sickle cell disease, thalassemia, bone marrow failure, and immune disorders. The transplant aims to replace the diseased blood-forming cells with healthy ones from the donor.
This trial tests a stem cell transplant from a family donor whose tissue type is only partly matched, for adults with blood cancers who don't have a fully matched sibling or other closely matched donor. The goal is to make transplant possible for more patients.
This trial offers a stem cell transplant using a half-matched family donor and/or cord blood for people with high-risk or hard-to-treat cancers or blood disorders. It aims to provide a treatment option when a perfectly matched donor is not available.
Hear when a new aGVHD trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.